5.919USD+0.74%Mkt Cap: 102.47M USDP/E: —Last update: 2026-06-01
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap102.47M USD
Enterprise Value79.79M USD
Revenue (TTM)37.16M USD
Gross Profit32.14M USD
Net Income (TTM)-17.89M USD
Revenue/Share2.731 USD
Last Price5.919 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS92511W1080
Valuation
P/E (Trailing)—
P/E (Forward)-4.63
PEG—
EV/EBITDA-6.11
EV/Revenue2.15
P/S2.66
P/B4.00
EPS (TTM)-1.10
EPS (Forward)-1.24
52W Range
3.28040% of range9.821
52W High9.821 USD
52W Low3.280 USD
Profitability
Gross Margin90.33%
Oper. Margin-193.41%
EBITDA Margin-35.14%
Profit Margin-50.27%
ROE-72.29%
ROA-37.95%
Growth
Revenue Growth46.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.63M USD
CapEx (TTM)—
FCF Margin-32.72%
FCF Yield-11.87%
Net Debt-19.16M USD
Net Debt/EBITDA1.47
Balance Sheet
Debt/Equity0.07
Current Ratio2.10
Quick Ratio1.75
Book Value/Sh1.440 USD
Cash/Share1.199 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 25, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)15.54 USD
Target Range10.00 USD – 20.00 USD
# Analysts5
Ownership
Shares Out.17.18M
Float7.90M
Insiders48.69%
Institutions27.87%
Short Interest
Short Ratio4.2d
Short % Float4.67%
Short % Out.2.40%
Shares Short412.48K
Short (prev mo.)581.33K
Technical
SMA 506.104 (-3.0%)
SMA 2005.903 (+0.3%)
Beta1.55
S&P 52W Chg27.70%
Avg Vol (30d)76.75K
Avg Vol (10d)45.29K
Technical Indicators
RSI (14)43.0
MACD-0.1375
MACD Signal-0.0139
MACD Hist.-0.1236
BB Upper8.383 USD
BB Middle6.665 USD
BB Lower4.946 USD
BB Width51.56%
ATR (14)0.5569 USD
Vol Ratio (20d)0.27x